These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18956646)

  • 1. [Study on expression and methylation of caveolin 1 gene in non-small cell lung cancers].
    Zhang YX; Chen HL; Ye B; Yang F; Yu LY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):300-4. PubMed ID: 18956646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
    Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma.
    Chen HL; Fan LF; Gao J; Ouyang JP; Zhang YX
    Oncol Rep; 2011 Feb; 25(2):359-66. PubMed ID: 21165568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
    Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
    Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
    Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Oncogene; 2001 Mar; 20(14):1765-70. PubMed ID: 11313923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
    Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of caveolin-1 expression in primary lung cancer].
    Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation of FBLN-3 gene and clinicopathological significance in non-small cell lung carcinoma.
    Wang R; Zhang YW; Chen LB
    Lung Cancer; 2010 Aug; 69(2):239-44. PubMed ID: 19913326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
    Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation markers and early recurrence in stage I lung cancer.
    Brock MV; Hooker CM; Ota-Machida E; Han Y; Guo M; Ames S; Glöckner S; Piantadosi S; Gabrielson E; Pridham G; Pelosky K; Belinsky SA; Yang SC; Baylin SB; Herman JG
    N Engl J Med; 2008 Mar; 358(11):1118-28. PubMed ID: 18337602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC.
    Pesta M; Kulda V; Topolcan O; Safranek J; Vrzalova J; Cerny R; Holubec L
    Anticancer Res; 2009 Nov; 29(11):4535-9. PubMed ID: 20032402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of FBN2 in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Lung Cancer; 2005 Oct; 50(1):43-9. PubMed ID: 15951052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.